Biotechs May Have Broken Their DowntrendBiotechnology stocks have struggled this year along with the broader health-care sector, but some traders may think a bullish turn has begun.
The first pattern on today’s chart of the Nasdaq Biotechnology Index is the series of lower highs since early April. NBI closed above that falling trendline
